NIH-funded research R01 grant

Developing low-cost devices for generating nitric oxide gas for medical use

Official title: Optimization of Cu(II)-ligand catalysts, membrane materials, and coatings for O2-tolerant, portable, and low-cost electrochemical nitric oxide generation devices/catheters

Funded at University of Michigan at Ann Arbor · NIH-11019769 · Data updated 2026-11-12

This study is working on making easy-to-use and affordable devices that produce a helpful gas called nitric oxide, which can improve treatments for lung problems and help keep catheters safe from infections and clots.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$452,261
NIH project number5R01HL168369-02
Project IDNIH-11019769 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include patients with chronic respiratory conditions such as cystic fibrosis, tuberculosis, or COVID-19, as well as those who require intravenous catheterization.

Less likely to help

Patients who do not have respiratory conditions or do not require catheterization may not benefit from this research.

What this research studies

This research focuses on creating portable and affordable devices that generate nitric oxide (NO) gas, which has important therapeutic applications in treating lung conditions and preventing infections. The approach involves using a novel electrochemical method to produce high-purity NO gas from nitrite ions, utilizing Cu(II)-ligand complexes. This method aims to improve the delivery of NO for inhalation therapy and to coat intravenous catheters to reduce infection and clotting risks. Patients may benefit from enhanced treatments for respiratory diseases and improved safety in catheter use.

Why it matters

Potential benefit: If successful, this research could lead to more effective and accessible treatments for patients with respiratory diseases and those requiring intravenous catheters.

How similar studies have gone: Previous research has shown promise in using nitric oxide for therapeutic purposes, indicating that this approach could be a significant advancement in treatment options.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Lehnert, Nicolai — University of Michigan at Ann Arbor
  • Study coordinator: Lehnert, Nicolai

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.